31 studies found for:    NIAID | Open Studies | Exclude Unknown
Show Display Options
Download search resultsDownload the search results for:
NIAID | Open Studies | Exclude Unknown (31 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Conditions: MUD Transplant;   AlloPBSC;   Congenital Immunodeficiencies;   HLA Matched Transplant;   BMT
Interventions: Drug: Busulfan;   Drug: Campath-1 H;   Drug: Sirolimus;   Procedure: BMT;   Procedure: Apheresis;   Procedure: Total Body Irradiation;   Procedure: GCSF Injections
2 Recruiting Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
Condition: Proteogenomic Monitoring in Liver Transplant Recipients
Intervention:
3 Recruiting Serial Blood and Urine Monitoring Study in Kidney Transplant Recipients
Condition: Kidney Transplantation
Intervention:
4 Recruiting Collection of Samples and Data for the National Marrow Donor Program Repository
Condition: Hematopoietic Stem Cell Transplantation
Intervention:
5 Recruiting Bone Marrow Transplantation and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
Condition: Kidney Transplantation
Interventions: Biological: Antithymocyte globulin (ATG);   Drug: Fludarabine;   Drug: Low dose Pre-transplant cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Methylprednisolone;   Biological: Bone Marrow;   Drug: MESNA;   Drug: Mycophenolate mofetil (MMF);   Drug: Prednisone;   Drug: Filgrastim;   Drug: High dose post-transplant cyclophosphamide
6 Available Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Mycophenolic acid
7 Recruiting Safety and Efficacy of a Steroid-free, Calcineurin Inhibitor-free, Belatacept-based Immunosuppressive Regimen
Conditions: Kidney Transplantation;   Transplantation
Interventions: Biological: Anti-thymocyte Globulin (Rabbit);   Biological: Belatacept;   Drug: Methylprednisolone;   Biological: Basiliximab;   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus
8 Recruiting Allo-antibodies in Pediatric Heart Transplantation
Condition: Pediatric Heart Transplantation
Interventions: Drug: Induction Therapy (anti-T cell antibody induction);   Drug: Tacrolimus (Prograf);   Drug: Mycophenolate Mofetil- MMF (CellCept);   Procedure: Intraoperative plasma exchange/pheresis;   Procedure: Short-term post-operative plasmapheresis;   Drug: Post-transplant course of intravenous immunoglobulin (IVIG) therapy.;   Drug: Prednisone
9 Recruiting Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation
Conditions: Transplantation;   Organ Transplantation;   Heart Transplantation
Interventions: Drug: Bortezomib;   Procedure: Plasmapheresis on days 0, 1 and 2.
10 Recruiting Research Study of ATG and Rituximab in Renal Transplantation
Condition: Acute Kidney Injury
Interventions: Drug: ATG;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Sirolimus;   Drug: MMF
11 Recruiting Optimization of NULOJIX® (Belatacept) Usage as a Means of Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Condition: Pancreas and Kidney Transplant
Interventions: Biological: Belatacept;   Drug: methylprednisolone;   Biological: Anti-thymocyte Globulin;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
12 Recruiting Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Condition: Transplantation, Liver
Intervention: Other: Immunosuppression withdrawal (ISW)
13 Recruiting Genomics of Kidney Transplantation
Condition: Kidney Transplantation
Intervention:
14 Recruiting Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Condition: Kidney Transplant
Interventions: Drug: Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal;   Drug: MMF/Tacrolimus/Prednisone
15 Not yet recruiting Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
Condition: Chronic Granulomatous Disease
Intervention:
16 Recruiting Delayed Tolerance in Recipients of Living Kidney Allografts by Donor Stem Cell Infusion
Condition: Kidney Transplantation
Intervention: Biological: Hematopoietic Stem Cell Transplant/novel platform technology
17 Not yet recruiting Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Condition: Granulomatous Disease, Chronic
Intervention:
18 Recruiting Study of the Complications Associated With Certain Stem Cell Transplants
Conditions: Stem Cell Transplantation, Hematopoietic;   Complications;   Infection
Intervention:
19 Not yet recruiting Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990
Condition: Wiskott-Aldrich Syndrome
Intervention:
20 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil

Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results
Indicates status has not been verified in more than two years